Sanofi (SNY) Q1 Earnings In Line, Sales Miss Estimates, Stock Up [Yahoo! Finance]
Sanofi - American Depositary Shares (SNY)
US:NYSE Investor Relations:
sanofi.com/en/investors
Company Research
Source: Yahoo! Finance
Earnings of €1.78 per share declined 17.6% on a reported basis and 7.4% on a constant currency rate (“CER”) basis. Net sales rose 2.4% on a reported basis to $11.35 billion (€10.46 billion). Exchange rate movements hurt sales by 4.3% in the quarter. Sales rose 6.7% on a CER basis. Sales missed the Zacks Consensus Estimate of $11.75 billion. Sales rose 7.3% at CER in the United States and 13.8% in the Rest of the World (including China, Japan, Brazil and Russia) but declined 4% in Europe. All growth rates mentioned below are on a year-on-year basis and at CER. Segment Performance Sanofi's Biopharma segment includes Pharma and Vaccines. Biopharma sales rose 6.3% in the quarter to €8.94 billion. Pharma sales increased 6.4% to €7.76 billion, mainly driven by Dupixent and new product launches. Dupixent Dupixent generated sales of €2.84 billion in the quarter, up 24.9% year over year. Sales of the drug in the United States rose 16.8%, driven by strong demand for its approv
Show less
Read more
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNY alerts
High impacting Sanofi - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
SNY
News
- Global Graft Versus Host Disease (GVHD) Clinical Trials Review 2024 [Yahoo! Finance]Yahoo! Finance
- GSK knew about Zantac cancer risk, attorneys tell jury in first trial [Reuters]Reuters
- GSK knew about Zantac cancer risk, attorneys tell jury in first trial [Yahoo! Finance]Yahoo! Finance
- Regeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales [Yahoo! Finance]Yahoo! Finance
- E2open Announces Connect Europe 2024 Client Award Winners [Yahoo! Finance]Yahoo! Finance
SNY
Analyst Actions
- 2/12/24 - TheStreet
SNY
Sec Filings
- 5/2/24 - Form 6-K
- 4/25/24 - Form 6-K
- 4/4/24 - Form F-3ASR
- SNY's page on the SEC website